TABLE 3.
List of peptide-based self-assembled nanostructures for drug delivery applications.
| Peptide nanostructure | Carrier material | Drug (Disease) | References |
| Nanofibers | RAD16-II AcN-(RARADADA)2-CNH2 | IGF-1 (Myocardial infarction) | Davis et al., 2006 |
| Nanofibers coated with chitosan | Leucine-enkephalin NH2-Y(-O-palmitoyl)GGFL-OH | Enkephalin (Pain) | Lalatsa et al., 2015 |
| Nanofibers coated with chitosan | NH2-Y(-O-palmitoyl) GGFLR-OH | Dalargin (Pain) | Mazza et al., 2013 |
| Nanofibers | Palmitoyl-A4G3E3 | Camptothecin (Cancer) | Soukasene et al., 2011 |
| Nanofibers | Palmitoyl-V2A2E2K | Dexamethasone (Inflammation) | Webber et al., 2012 |
| Nanofibers | Palmitoyl-G3A4IKVAV | Spinal cord injury | Tysseling-Mattiace et al., 2008 |
| Nanofibers | Palmitoyl-(K)-V3E3SGGGYPVH PST-NH2 | Bone morphogenetic protein-2 (Spinal arthrodesis) | Lee et al., 2015 |
| Nanoparticles | Polylactide-V6K2(VVVVVVKK) | Doxorubicin, Paclitaxel (Cancer) | Jabbari et al., 2013 |
| Nanotubes | Lanreotide NH2-(D)Naph-CY(D)WKVCT-CONH2 | Acromegaly | Freda et al., 2005; Theodoropoulou and Stalla, 2013 |